Bumper Offer - Urjas oil Just @ Rs. 1
Keto Cream 30gm is a commercial drug that is prescribed in the form of Cream. It is typically used for the treatment of Fungal Infections. Other than this, Keto Cream 30gm has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Keto Cream 30gm depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
While these are the most often observed Keto Cream 30gm side effects, there are can be others also. These have been listed below. Such side effects of Keto Cream 30gm normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Keto Cream 30gm has a Moderate effect for pregnant women and Safe effect on lactating mothers. In addition, Keto Cream 30gm's effects on the liver, heart and kidney are discussed below in the Keto Cream 30gm related warnings section.
Keto Cream 30gm is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease are examples of such conditions. Other contraindications of Keto Cream 30gm have been discussed in the sections ahead.
Additionally, Keto Cream 30gm may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Keto Cream 30gm is considered not safe while driving, and is not addictive.
Keto Cream 30gm is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Keto Cream 30gm is used -
Moderate
Mild
Is the use of Keto Cream 30gm safe for pregnant women?
Pregnant women may experience moderate side effects from Keto. It is best to stop taking Keto immediately and inform your doctor if you notice any discomfort.
Is the use of Keto Cream 30gm safe during breastfeeding?
Keto does not show any side effects in breastfeeding women.
What is the effect of Keto Cream 30gm on the Kidneys?
Keto is completely safe for kidneys.
What is the effect of Keto Cream 30gm on the Liver?
Use of Keto may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of Keto Cream 30gm on the Heart?
Side effects of Keto rarely affect the heart.
Keto Cream 30gm should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Keto Cream 30gm unless your doctor advises you to do so -
Is this Keto Cream 30gm habit forming or addictive?
Keto Cream 30gm is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Keto Cream 30gm can make you feel drowsy.
Is it safe?
Yes, Keto Cream 30gm is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Keto Cream 30gm is unable to treat or cure mental disorders.
Interaction between Food and Keto Cream 30gm
Taking Keto Cream 30gm with food does not harm your health.
Interaction between Alcohol and Keto Cream 30gm
Taking Keto Cream 30gm with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Nizoral (ketoconazole)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 792-793
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
